Building awareness and providing solutions to create better air for healthcare.
Aerobiotix, Inc. continually commissions independent and collaborative research on our technologies, partnering with leading biomedical institutions globally. In doing so, many scientific studies have been produced to show the effectiveness of HEPA-Ultraviolet air recirculation (HUAIRS) technology. These studies range from laboratory testing, case studies, conference presentations and peer-reviewed papers.
- Reduced bacterial level 80 to 20 CFU/m³ in orthopedic OR¹
- Reduced bacterial levels 67% in general surgery OR²
- Reduced bacterial levels 41% in routine care³
- Reduced viable biological particle levels up to 80% in orthopedic OR⁴
- Reduced incidence of surgical site infection in joint procedures⁵
- Reduced electrocautery smoke plume levels⁶
- Reduced cardiac heater-cooler emissions
Messina G., et al. Presented at EUPHA 2019. During mobile device operation, the amount of particulate matter remains significantly lower, reducing the probability of SSI.
Presented at The European Bone and Joint Infection Society, 2017, by W.R. Walsh, PhD, et al., reported 99.5% reduction in viable particle counts.
Parvizi, MS, MD, FRCS, et al. American Journal of Infection Control, 2017 reported 53%-67% reduction of airborne bacterial content in active ORs.
Curtis, G.L., MD, et al. The Journal of Arthroplasty, 2017 reported the C-UVC units significantly reduce total and viable particles counts.
W. R. Walsh, PhD, Airborne bacteria-laden particles in healthcare settings are now being recognized as a contributing cause of hospital acquired infections (HAI), and surgical site infections (SSI). OR Air Supplemental System reduced mean bacterial CFU/m³ by 57%.
Sue Barnes, RN, CIC, FAPIC. This study was designed to test the effectiveness of the novel AEROBIOTIX (ABX) crystalline ultraviolet (C-UVC) germicidal irradiation in-room air disinfection and filtration technology on reducing airborne particle contamination in the OR. Results confirm 99.97% inactivation efficiency of aerosolized bacteria.
W.R. Walsh, PhD., conducted a study with scanning electron microscopy to evaluate the Illuvia filtration cartridge. A significant number of airborne particulates was detected within the cartridge after each surgical procedure.
Anis, H. MD, Curtis, G. MD, et al., Cleveland Clinic, Presented at MSIS 2018. This study demonstrated a significant reduction of total and viable particles as well as CFUs in active TJA surgeries.
Werner Bischoff, MD PhD, FSHEA, Gregory Russell MS, Elisabeth Willard AAS, John Stehle Jr PhD. American Journal of Infection Control, 2019. Aerosol transmission of pathogens can result in the rapid spread of disease. The mobile air recirculation system significantly decreased the bacterial load by over 40%.
The Impact of Supplemental Intraoperative Air Decontamination on the Outcome of Total Joint Arthroplasty
Cook, T., DO, Piatt, C., DO, Barnes, S. BSN, Edmiston, Jr., C.E. PhD. The Journal of Arthroplasty, 2018. While PJI is multifactorial in nature, this study suggests the use of intraoperative supplemental air decontamination significantly reduced the overall risk of PJI.
Russell Nassof, JD; Kathy Warye, Maureen Spencer, MEd, RN, CIC, FAPIC. Infection Control Today, September 2018. While there is a host of factors in OR environment and practice that can contribute to SSI, there is a growing body of evidence which suggests that air quality merits heightened attention on the part of the infection prevention community.
AEROBIOTIX technology previously demonstrated statistically significant reductions in total airborne particulates, viable particulates, and airborne bacteria when deployed in active operating rooms. The study was performed in a single OR at a 300-bed community medical center in Atlanta, Georgia, USA.
Carrico, R.M. PhD DNP FSHEA CIC, Warye, K. The HUAIRS system represents a potential solution for the mitigation of bioaerosol emissions in order to eliminate SSI risk due to HCU in cardiac ORs.
 Walsh, W.R., Bradford, N., Davies G. MD, Oliver R. PhD, Verhuel, R. MBBS, FRACS, Bruce, W., MBBS, FRACS. Total and viable airborne particulates during orthopaedic surgical procedures. Infection, Disease & Health (2017). Parvizi, J., MS, MD, FRCS, Barnes, S., RN, CIC, Shohat, N., MD, Edmiston, C., MS, PhD. Environment of care: Is it time to reassess microbial contamination of the operating room air as a risk factor for surgical site infection in total joint arthroplasty? American Journal of Infection Control (2017). Bischoff, Werner, MD, PhD, FSHEA, Russell, G.B., MS, Willard, E.S., and Stehle Jr., J., PhD. The Impact of a Novel, Mobile Air Purification System on the Bacterial Air Burden during Routine Care (SHEA 2018). Curtis, G.L., MD, Four, M., MD, Jawad, Michael, BS, Kila, MS, Barroom, W.K., MD, Higuera, C.A., MD. Reduction of Particles in the Operating Room Using Ultraviolet Air Disinfection and Recirculation Units. The Journal of Arthroplasty (2017). Edmiston, C., MS PhD. Publication pending Barnes, S., RN, CIC, FAPIC. Publication accepted AORN Journal Carrico, R., PhD, RN, FSHEA, CIC. Publication pending